- Advertisement -
Wesfarmers’ (ASX: WES) attempt to diversify its retail offering with one of Australia’s leading pharmacy chains is one step closer to getting over the line after entering into a scheme implementation deed (SID) to buy all remaining shares in Australian Pharmaceutical Industries (ASX: API).
It has…
